COVID - 19肺炎临床和影像学恢复患者的持续呼吸困难:检查毛细血管肺容量持续障碍的探针。

IF 2.3
Multidisciplinary Respiratory Medicine Pub Date : 2022-09-30 eCollection Date: 2022-01-12 DOI:10.4081/mrm.2022.875
Roberto W Dal Negro, Paola Turco, Massimiliano Povero
{"title":"COVID - 19肺炎临床和影像学恢复患者的持续呼吸困难:检查毛细血管肺容量持续障碍的探针。","authors":"Roberto W Dal Negro,&nbsp;Paola Turco,&nbsp;Massimiliano Povero","doi":"10.4081/mrm.2022.875","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>During SARS-CoV-2 infection, diffuse alveolar damage and pulmonary microvascular abnormalities are critical events that result in gas exchange disorders of varying severity and duration. The only measure of carbon monoxide (CO) diffusing capacity (DL<sub>CO</sub>) is unable to distinguish the alveolar from the vascular side of present and residual diffusive abnormalities, and measure of nitric oxide (NO) diffusing capacity (DL<sub>NO</sub>) is also recommended. Dyspnoea, despite being understudied, persists in a significant proportion of patients for several weeks after hospital discharge. The goal of this study was to look into the underlying cause of long-term dyspnoea in patients who were \"clinically and radiologically recovered\" from COVID pneumonia by assessing DL<sub>CO</sub> and DL<sub>NO</sub> at the same time.</p><p><strong>Methods: </strong>Patients of both genders, aged ≥18 years, who had a CT scan showing complete resolution of COVID-related parenchymal lesions were recruited consecutively. Spirometrical volumes, blood haemoglobin, SpO<sub>2</sub>, DL<sub>CO</sub>, DL<sub>NO</sub> and capillary blood volume (Vc) were measured. Data from patients without dyspnoea (group A) and from patients still claiming dyspnoea after 12-16 weeks from their hospital discharge (group B) were statistically compared.</p><p><strong>Results: </strong>Forty patients were recruited: 19 in group A and 21 in group B. Groups were comparable for their general characteristics and spirometrical volumes, that were in the normal range. Mean values for DL<sub>CO</sub>, DL<sub>NO</sub> and Vc were significantly and substantially lower than predicted only in patients of group B (p<0.011; p<0.0036; p<0.02; p<0.001, respectively). The DL<sub>NO</sub>/ DL<sub>CO</sub> ratio was higher in group B (p<0.001) and inversely correlated to Vc values (-0.3636).</p><p><strong>Conclusions: </strong>The single-breath, simultaneous measurement of DL<sub>CO</sub>, DL<sub>NO</sub>, and Vc demonstrated that problems with blood gas exchange can persist even after parenchymal lesions have healed completely. Regardless of the normality of spirometric volumes, there was a significant reduction in lung capillary blood volume. In these patients, the cause of long-term dyspnoea may be related to hidden abnormalities in the vascular side of diffusive function. In the near future, novel therapeutic approaches against residual and symptomatic signs of long-COVID are possible.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"17 1","pages":"875"},"PeriodicalIF":2.3000,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d8/02/mrm-17-1-875.PMC9577559.pdf","citationCount":"2","resultStr":"{\"title\":\"Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause.\",\"authors\":\"Roberto W Dal Negro,&nbsp;Paola Turco,&nbsp;Massimiliano Povero\",\"doi\":\"10.4081/mrm.2022.875\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>During SARS-CoV-2 infection, diffuse alveolar damage and pulmonary microvascular abnormalities are critical events that result in gas exchange disorders of varying severity and duration. The only measure of carbon monoxide (CO) diffusing capacity (DL<sub>CO</sub>) is unable to distinguish the alveolar from the vascular side of present and residual diffusive abnormalities, and measure of nitric oxide (NO) diffusing capacity (DL<sub>NO</sub>) is also recommended. Dyspnoea, despite being understudied, persists in a significant proportion of patients for several weeks after hospital discharge. The goal of this study was to look into the underlying cause of long-term dyspnoea in patients who were \\\"clinically and radiologically recovered\\\" from COVID pneumonia by assessing DL<sub>CO</sub> and DL<sub>NO</sub> at the same time.</p><p><strong>Methods: </strong>Patients of both genders, aged ≥18 years, who had a CT scan showing complete resolution of COVID-related parenchymal lesions were recruited consecutively. Spirometrical volumes, blood haemoglobin, SpO<sub>2</sub>, DL<sub>CO</sub>, DL<sub>NO</sub> and capillary blood volume (Vc) were measured. Data from patients without dyspnoea (group A) and from patients still claiming dyspnoea after 12-16 weeks from their hospital discharge (group B) were statistically compared.</p><p><strong>Results: </strong>Forty patients were recruited: 19 in group A and 21 in group B. Groups were comparable for their general characteristics and spirometrical volumes, that were in the normal range. Mean values for DL<sub>CO</sub>, DL<sub>NO</sub> and Vc were significantly and substantially lower than predicted only in patients of group B (p<0.011; p<0.0036; p<0.02; p<0.001, respectively). The DL<sub>NO</sub>/ DL<sub>CO</sub> ratio was higher in group B (p<0.001) and inversely correlated to Vc values (-0.3636).</p><p><strong>Conclusions: </strong>The single-breath, simultaneous measurement of DL<sub>CO</sub>, DL<sub>NO</sub>, and Vc demonstrated that problems with blood gas exchange can persist even after parenchymal lesions have healed completely. Regardless of the normality of spirometric volumes, there was a significant reduction in lung capillary blood volume. In these patients, the cause of long-term dyspnoea may be related to hidden abnormalities in the vascular side of diffusive function. In the near future, novel therapeutic approaches against residual and symptomatic signs of long-COVID are possible.</p>\",\"PeriodicalId\":49031,\"journal\":{\"name\":\"Multidisciplinary Respiratory Medicine\",\"volume\":\"17 1\",\"pages\":\"875\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2022-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d8/02/mrm-17-1-875.PMC9577559.pdf\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Multidisciplinary Respiratory Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4081/mrm.2022.875\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/12 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multidisciplinary Respiratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4081/mrm.2022.875","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/12 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

背景:在SARS-CoV-2感染期间,弥漫性肺泡损伤和肺微血管异常是导致不同程度和持续时间的气体交换障碍的关键事件。一氧化碳(CO)弥散能力(DLCO)的唯一测量方法是无法区分肺泡和血管侧的现有和残留弥散异常,同时也推荐测量一氧化氮(NO)弥散能力(DLNO)。尽管对呼吸困难的研究还不够充分,但很大比例的患者在出院后仍会持续数周。本研究的目的是通过同时评估DLCO和DLNO,探讨COVID - 19肺炎“临床和放射学恢复”患者长期呼吸困难的根本原因。方法:连续招募CT扫描显示新冠肺炎相关实质病变完全消退的患者,年龄≥18岁,男女不限。测定肺活量、血红蛋白、SpO2、DLCO、DLNO、毛细血管血容量(Vc)。无呼吸困难患者(A组)和出院后12-16周仍有呼吸困难患者(B组)的数据进行统计学比较。结果:共纳入40例患者:A组19例,b组21例。两组患者的一般特征和肺活量均在正常范围内。仅B组患者DLCO、DLNO和Vc的平均值显著低于预测值(pNO/ DLCO比值高于B组)。结论:单次呼吸同时测量DLCO、DLNO和Vc表明,即使实质病变完全愈合,血气交换问题仍可能持续存在。尽管肺活量正常,但肺毛细血管血容量明显减少。在这些患者中,长期呼吸困难的原因可能与血管侧弥散功能的隐性异常有关。在不久的将来,针对长期covid的残留和症状体征的新治疗方法是可能的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause.

Background: During SARS-CoV-2 infection, diffuse alveolar damage and pulmonary microvascular abnormalities are critical events that result in gas exchange disorders of varying severity and duration. The only measure of carbon monoxide (CO) diffusing capacity (DLCO) is unable to distinguish the alveolar from the vascular side of present and residual diffusive abnormalities, and measure of nitric oxide (NO) diffusing capacity (DLNO) is also recommended. Dyspnoea, despite being understudied, persists in a significant proportion of patients for several weeks after hospital discharge. The goal of this study was to look into the underlying cause of long-term dyspnoea in patients who were "clinically and radiologically recovered" from COVID pneumonia by assessing DLCO and DLNO at the same time.

Methods: Patients of both genders, aged ≥18 years, who had a CT scan showing complete resolution of COVID-related parenchymal lesions were recruited consecutively. Spirometrical volumes, blood haemoglobin, SpO2, DLCO, DLNO and capillary blood volume (Vc) were measured. Data from patients without dyspnoea (group A) and from patients still claiming dyspnoea after 12-16 weeks from their hospital discharge (group B) were statistically compared.

Results: Forty patients were recruited: 19 in group A and 21 in group B. Groups were comparable for their general characteristics and spirometrical volumes, that were in the normal range. Mean values for DLCO, DLNO and Vc were significantly and substantially lower than predicted only in patients of group B (p<0.011; p<0.0036; p<0.02; p<0.001, respectively). The DLNO/ DLCO ratio was higher in group B (p<0.001) and inversely correlated to Vc values (-0.3636).

Conclusions: The single-breath, simultaneous measurement of DLCO, DLNO, and Vc demonstrated that problems with blood gas exchange can persist even after parenchymal lesions have healed completely. Regardless of the normality of spirometric volumes, there was a significant reduction in lung capillary blood volume. In these patients, the cause of long-term dyspnoea may be related to hidden abnormalities in the vascular side of diffusive function. In the near future, novel therapeutic approaches against residual and symptomatic signs of long-COVID are possible.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Multidisciplinary Respiratory Medicine
Multidisciplinary Respiratory Medicine Medicine-Pulmonary and Respiratory Medicine
自引率
0.00%
发文量
23
期刊介绍: Multidisciplinary Respiratory Medicine is the official journal of the Italian Respiratory Society - Società Italiana di Pneumologia (IRS/SIP). The journal publishes on all aspects of respiratory medicine and related fields, with a particular focus on interdisciplinary and translational research. The interdisciplinary nature of the journal provides a unique opportunity for researchers, clinicians and healthcare professionals across specialties to collaborate and exchange information. The journal provides a high visibility platform for the publication and dissemination of top quality original scientific articles, reviews and important position papers documenting clinical and experimental advances.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信